1498 — PuraPharm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual balance sheet for PuraPharm, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	91.4	59.7	75.8	20.1	12.8
Net Total Accounts Receivable
Net Total Receivables	222	300	156	113	57.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	608	611	486	350	268
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	554	492	431	397	355
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,375	1,206	1,016	844	716
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	592	665	665	571	491
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	863	804	758	691	605
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	512	402	258	153	111
Total Liabilities & Shareholders' Equity	1,375	1,206	1,016	844	716
Total Common Shares Outstanding